Quince Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QNCX and other ETFs, options, and stocks.

About QNCX

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. 

CEO
Dirk Thye
CEODirk Thye
Employees
38
Employees38
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2012
Founded2012
Employees
38
Employees38

QNCX Key Statistics

Market cap
29.65M
Market cap29.65M
Price-Earnings ratio
-0.23
Price-Earnings ratio-0.23
Dividend yield
Dividend yield
Average volume
23.54K
Average volume23.54K
High today
$29.89
High today$29.89
Low today
$27.21
Low today$27.21
Open price
$27.21
Open price$27.21
Volume
48.82K
Volume48.82K
52 Week high
$909.98
52 Week high$909.98
52 Week low
$4.99
52 Week low$4.99

Stock Snapshot

Quince Therapeutics(QNCX) stock is priced at $29.48, giving the company a market capitalization of 29.65M. It carries a P/E multiple of -0.23.

On 2026-09-20, Quince Therapeutics(QNCX) stock moved within a range of $27.21 to $29.89. With shares now at $29.48, the stock is trading +8.3% above its intraday low and -1.4% below the session's peak.

Trading activity shows a volume of 48.82K, compared to an average daily volume of 23.54K.

The stock's 52-week range extends from a low of $4.99 to a high of $909.98.

The stock's 52-week range extends from a low of $4.99 to a high of $909.98.

QNCX News

TipRanks 6d
Quince Therapeutics Divests Italian Subsidiary, Refocuses Strategy

Quince Therapeutics ( (QNCX) ) has issued an announcement. On September 8, 2026, Quince Therapeutics completed the sale of all equity in its Italian subsidiary...

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own QNCX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.